Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) |
|---|---|
| Disease/Condition | Lung Cancer,Solid Tumor,Lung Diseases,Carcinoma,Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Haiying Cheng, MD |
| Contact Name | Remy Lambert |
| Contact Email | rlambert@montefiore.org |
| Protocol Number | 2016-7018 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Early-stage NSCLC |
| Adult, Pediatric, Both | Adult |
